Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
101.36
-0.63 (-0.62%)
At close: Dec 5, 2025, 4:00 PM EST
101.31
-0.05 (-0.05%)
After-hours: Dec 5, 2025, 7:46 PM EST
Medtronic Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Medtronic stock ranges from a low of $98 to a high of $118. The average analyst price target of $108.63 forecasts a 7.17% increase in the stock price over the next year.
Price Target: $108.63 (+7.17%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Medtronic stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 8 | 5 | 5 | 6 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 15 | 15 | 16 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $109 → $111 | Buy | Maintains | $109 → $111 | +9.51% | Nov 20, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $103 → $110 | Hold | Maintains | $103 → $110 | +8.52% | Nov 20, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $107 → $117 | Buy | Maintains | $107 → $117 | +15.43% | Nov 19, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $111 → $118 | Buy | Maintains | $111 → $118 | +16.42% | Nov 19, 2025 |
| UBS | UBS | Hold Maintains $95 → $102 | Hold | Maintains | $95 → $102 | +0.63% | Nov 19, 2025 |
Financial Forecast
Revenue This Year
36.42B
from 33.54B
Increased by 8.60%
Revenue Next Year
38.55B
from 36.42B
Increased by 5.83%
EPS This Year
5.70
from 3.61
Increased by 57.85%
EPS Next Year
6.18
from 5.70
Increased by 8.41%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.9B | 40.8B | |||
| Avg | 36.4B | 38.5B | |||
| Low | 35.2B | 37.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 13.1% | 12.0% | |||
| Avg | 8.6% | 5.8% | |||
| Low | 5.1% | 1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.96 | 6.56 | |||
| Avg | 5.70 | 6.18 | |||
| Low | 5.52 | 5.90 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 65.2% | 15.1% | |||
| Avg | 57.9% | 8.4% | |||
| Low | 52.8% | 3.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.